Chondrosarcoma
📧 Sign up to get email alerts when something new happens for Chondrosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection
A completed clinical trial comparing intralesional curettage versus surgical resection for Grade 2 chondrosarcoma.
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors [Phase 2]
Phase 2 trial of AdAPT-001 in patients with sarcoma and refractory solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy [NA]
This clinical trial update outlines a study comparing daily 1-beam versus 2-beam proton therapy to assess toxicity and efficacy in chordoma,…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas [Phase 1]
Itacitinib was studied in a Phase 1 trial for patients with refractory metastatic/advanced sarcomas, but the study status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma [Phase 2]
Phase 2 clinical trial update for imatinib in patients with advanced desmoid tumor and advanced chondrosarcoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma [Phase 2]
Phase 2 trial evaluating anlotinib with or without a PD-1 antibody for unresectable high-grade chondrosarcoma.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation [Phase 1, Phase 2]
Phase 1/2 trial evaluating FT-2102 in IDH1-mutant advanced solid tumors and gliomas; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma [Phase 2]
Phase 2 trial of pazopanib in surgically unresectable or metastatic chondrosarcoma completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Metformin And Chloroquine in IDH1/2-mutated Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial investigating metformin and chloroquine in IDH1/2-mutated solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Vismodegib in Treating Patients With Advanced Chondrosarcomas [Phase 2]
Phase 2 clinical trial evaluating vismodegib for advanced chondrosarcomas has posted results in 2019 and is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI [Phase 2]
Phase 2 clinical trial updating the use of ferumoxytol-enhanced MRI to differentiate bone sarcomas from osteomyelitis.
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Trial of Dasatinib in Advanced Sarcomas [Phase 2]
Phase 2 trial update for dasatinib in advanced sarcomas, with completed status and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas [Phase 2]
Phase 2 trial evaluating perifosine in chemo-insensitive sarcomas, including chondrosarcoma, alveolar soft-part sarcoma, and extraskeletal m…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma [Phase 2]
Phase II trial of nivolumab plus ipilimumab in non-resectable soft tissue and bone sarcomas, with exploration across several sarcoma subtype…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Proton Therapy for Chordomas and/or Chondrosarcomas
A completed clinical trial evaluated proton therapy for chordoma and chondrosarcoma.
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas [Phase 2]
A Phase II study of everolimus in patients with primary or relapsed chondrosarcoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/Phase 2 study evaluating charged particle radiotherapy for chordoma and chondrosarcoma at th…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors [Phase 2]
Phase 2 trial of linsitinib in patients with gastrointestinal stromal tumors (and related conditions) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Low Grade Chondrosarcoma Versus Enchondroma
This clinical trial update notes completion of a study comparing low-grade chondrosarcoma and enchondroma.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy [NA]
Completed clinical trial evaluating the effects of preoperative physical therapy in patients with lower extremity bone sarcomas; results are…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial results for Therapeutic Angiotensin-(1-7) in patients with unresectable metastatic sarcoma have results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma [Phase 2]
Phase 2 safety and efficacy study of saridegib (IPI-926) in patients with metastatic or locally advanced chondrosarcoma completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]
Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 [NA]
Clinical trial update for the extension protocol of IPI-926 (saridegib) for continuation of treatment; the study involving basal cell carcin…